Edwards Lifesciences CEO: Improving structural heart disease procedures is 'our No. 1 focus'

Edwards Lifesciences CEO Michael Mussallem tells CNBC's Jim Cramer that the medical equipment company has prioritized improving care for structural heart disease, which develops through wear and tear.

Revolutionized the treatment of heart disease, non invasive heart valve replacement
Stocks up

“There’s so many unmet needs amongst these patients,” Mussallem said pointing to replacing heart valves or holes in the heart as part of that focus.

“Were the ones who really focus on [structural heart disease],” Mussallem said. “We make it our number one focus. It's the only thing we feel like we need to do. There's so many unmet needs amongst these patients.”

“We expect to be able to do it with small catheters and do a little miracle on the tip of a catheter and have a quick recovery, as opposed to what used to be open-chest procedures,” he said.

For access to live and exclusive video from CNBC subscribe to CNBC PRO: https://www.cnbc.com/pro/?__source=yo...

» Subscribe to CNBC TV: https://cnb.cx/SubscribeCNBCtelevision
» Subscribe to CNBC: https://cnb.cx/SubscribeCNBC
» Subscribe to CNBC Classic: https://cnb.cx/SubscribeCNBCclassic

Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.

Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC

#CNBC
#CNBC TV